HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AT1R blockade in adverse milieus: role of SMRT and corepressor complexes.

Abstract
ANG II type 1 receptor blockade (AT1R-BLK) is used extensively to slow down the progression of proteinuric kidney diseases. We hypothesized that AT1R-BLK provides podocyte protection through regulation of silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) and vitamin D receptor (VDR) expression under adverse milieus such as high glucose and human immunodeficiency virus infection. Both AT1R-BLK and VDR agonists (VDAs) stimulated VDR complex formation that differed not only in their composition but also in their functionality. AT1R-BLK-induced VDR complexes contained predominantly unliganded VDR, SMRT, and phosphorylated histone deacetylase 3, whereas VDA-VDR complexes were constituted by liganded VDR and CREB-binding protein/p300. AT1R-BLK-induced complexes attenuated podocyte acetyl-histone 3 levels as well as cytochrome P-450 family 24A1 expression, thus indicating their deacetylating and repressive properties. On the other hand, VDA-VDR complexes not only increased podocyte acetyl-histone 3 levels but also enhanced cytochrome P-450 family 24A1 expression, thus suggesting their acetylating and gene activation properties. AT1R-BLK- induced podocyte SMRT inhibited expression of the proapoptotic gene BAX through downregulation of Wip1 and phosphorylation of checkpoint kinase 2 in high-glucose milieu. Since SMRT-depleted podocytes lacked AT1R-BLK-mediated protection against DNA damage, it appears that SMRT is necessary for DNA repairs during AT1R-BLK. We conclude that AT1R-BLK provides podocyte protection in adverse milieus predominantly through SMRT expression and partly through unliganded VDR expression in 1,25(OH)2D-deficient states; on the other hand, AT1R-BLK contributes to liganded VDR expression in 1,25(OH)2D-sufficient states.
AuthorsTejinder Singh, Kamesh Ayasolla, Partab Rai, Nirupama Chandel, Shabirul Haque, Rivka Lederman, Mohammad Husain, Vasupradha Vethantham, Amrita Chawla, Himanshu Vashistha, Moin A Saleem, Guohua Ding, Praveen N Chander, Ashwani Malhotra, Leonard G Meggs, Pravin C Singhal
JournalAmerican journal of physiology. Renal physiology (Am J Physiol Renal Physiol) Vol. 309 Issue 3 Pg. F189-203 (Aug 01 2015) ISSN: 1522-1466 [Electronic] United States
PMID26084932 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2015 the American Physiological Society.
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Apoptosis Regulatory Proteins
  • Co-Repressor Proteins
  • Histones
  • NCOR2 protein, human
  • Nuclear Receptor Co-Repressor 2
  • Protective Agents
  • Receptors, Calcitriol
  • Vitamin D3 24-Hydroxylase
  • Proteasome Endopeptidase Complex
  • Losartan
Topics
  • Acetylation
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Apoptosis Regulatory Proteins (biosynthesis)
  • Co-Repressor Proteins (drug effects)
  • DNA Damage
  • Dose-Response Relationship, Drug
  • Histones (metabolism)
  • Humans
  • Losartan (pharmacology)
  • Nuclear Receptor Co-Repressor 2 (physiology)
  • Podocytes (drug effects, enzymology)
  • Proteasome Endopeptidase Complex (drug effects)
  • Protective Agents (pharmacology)
  • Receptors, Calcitriol (drug effects)
  • Vitamin D3 24-Hydroxylase (biosynthesis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: